These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29605967)

  • 1. Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan.
    Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
    Cancer Med; 2018 May; 7(5):1870-1874. PubMed ID: 29605967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.
    Ladra MM; Szymonifka JD; Mahajan A; Friedmann AM; Yong Yeap B; Goebel CP; MacDonald SM; Grosshans DR; Rodriguez-Galindo C; Marcus KJ; Tarbell NJ; Yock TI
    J Clin Oncol; 2014 Nov; 32(33):3762-70. PubMed ID: 25332253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma.
    Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Hol ML; Bradley JA
    Acta Oncol; 2019 Oct; 58(10):1404-1409. PubMed ID: 31530120
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
    Indelicato DJ; Rotondo RL; Krasin MJ; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):968-976. PubMed ID: 31987977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
    Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
    Casey DL; Wexler LH; Wolden SL
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.
    Childs SK; Kozak KR; Friedmann AM; Yeap BY; Adams J; MacDonald SM; Liebsch NJ; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):635-42. PubMed ID: 21377294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan.
    Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
    Cancer Med; 2016 Jul; 5(7):1519-25. PubMed ID: 27165972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after proton beam therapy for pediatric tumors: a Japanese national survey.
    Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
    Cancer Sci; 2017 Mar; 108(3):444-447. PubMed ID: 28004469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy.
    Leiser D; Calaminus G; Malyapa R; Bojaxhiu B; Albertini F; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Walser M; Timmermann B; Lomax T; Schneider R; Weber DC
    Radiother Oncol; 2016 Jul; 120(1):163-8. PubMed ID: 27247053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pencil Beam Scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of Patients Treated at the Paul Scherrer Institute.
    Weber DC; Ares C; Albertini F; Frei-Welte M; Niggli FK; Schneider R; Lomax AJ
    Pediatr Blood Cancer; 2016 Oct; 63(10):1731-6. PubMed ID: 26701148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma.
    Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Radiother Oncol; 2019 May; 134():143-150. PubMed ID: 31005208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.
    Ladra MM; Edgington SK; Mahajan A; Grosshans D; Szymonifka J; Khan F; Moteabbed M; Friedmann AM; MacDonald SM; Tarbell NJ; Yock TI
    Radiother Oncol; 2014 Oct; 113(1):77-83. PubMed ID: 25443861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
    Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
    Kubeš J; Vondráček V; Andrlik M; Navrátil M; Sláviková S; Vítek P; Rosina J; Abrahámová J; Prausová J; Grebenyuk A; Dědečková K
    J Med Imaging Radiat Oncol; 2019 Dec; 63(6):829-835. PubMed ID: 31486267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.